Pharmacyte Biotech Inc (PMCB)

Apr 02, 2026

Director Weinstein receives 119,170 stock options at PharmaCyte Biotech (PMCB) - Stock Titan

Apr 02, 2026

Apr 02, 2026

Director at PharmaCyte Biotech (PMCB) gets 119,170 options - Stock Titan

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech (PMCB) director awarded 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech (PMCB) director receives 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech Shareholders Approve Governance and Equity Actions - TipRanks

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech (PMCB) wins approval for reverse split range and 2M new plan shares - Stock Titan

Apr 02, 2026

Mar 27, 2026

PMCB Stock Chart | PHARMACYTE BIOTECH INC (NASDAQ:PMCB) - ChartMill

Mar 27, 2026

Mar 20, 2026

Insider Sell: How liquid is PharmaCyte Biotech Inc stock2026 Setups & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026

PharmaCyte Biotech (PMCB) logs neutral Form 4 as 10% FEMASYS (FEMY) owner - Stock Titan

Mar 18, 2026

Mar 18, 2026

PharmaCyte Biotech (FEMY) reports 7.87% stake including warrants - Stock Titan

Mar 18, 2026

Mar 18, 2026

PharmaCyte Biotech, Inc. (PMCB) Q3 2026 10-Q Report: Financial Results, Stock Information, and SEC Filings - Minichart

Mar 18, 2026

Mar 17, 2026

PharmaCyte Biotech 10-Q: $0.0M Revenue, $(0.17) EPS (Q3), $(2.41) EPS (YTD) - TradingView

Mar 17, 2026

Mar 17, 2026

PharmaCyte Biotech (NASDAQ: PMCB) details Jan 2026 results and cash runway - Stock Titan

Mar 17, 2026

Mar 14, 2026

PharmaCyte Biotech delays quarterly report filing - MSN

Mar 14, 2026

Mar 12, 2026

Analyzing Prime Medicine (NYSE:PRME) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World

Mar 12, 2026

Mar 10, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 10, 2026

Mar 09, 2026

PharmaCyte Biotech (PMCB) seeks reverse split, equity plan boost at 2026 meeting - Stock Titan

Mar 09, 2026

Mar 07, 2026

Aug Catalysts: Can PharmaCyte Biotech Inc. stock weather global recessionWeekly Profit Summary & Safe Capital Growth Plans - Naître et grandir

Mar 07, 2026

Mar 05, 2026

PMCB Stock Jumps 25% After Company Sells Stake In Femasys - Stocktwits

Mar 05, 2026

Mar 04, 2026

PMCB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Feb 28, 2026

Technical Analysis - Intellectia AI

Feb 28, 2026

Feb 27, 2026

PharmaCyte Biotech (PMCB) seeks reverse split and 2M share plan boost at virtual meeting - Stock Titan

Feb 27, 2026

Feb 25, 2026

Day Trade: Can PharmaCyte Biotech Inc keep up with sector leadersJuly 2025 Trends & Free Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 25, 2026

Feb 20, 2026

PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 20, 2026

Feb 10, 2026

PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 5.9% Higher – Time to Buy? - Defense World

Feb 10, 2026

Feb 09, 2026

Volume Summary: What is SIM Acquisition Corp Is P E ratio telling usJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn

Feb 09, 2026

Feb 05, 2026

Dow Update: Is PharmaCyte Biotech Inc vulnerable to short sellersMarket Risk Summary & Verified Trade Idea Suggestions - baoquankhu1.vn

Feb 05, 2026

Jan 29, 2026

Is PharmaCyte Biotech Inc. trading at a discountWeekly Stock Report & Weekly High Momentum Picks - mfd.ru

Jan 29, 2026

Jan 19, 2026

Is PharmaCyte Biotech Inc. vulnerable to short sellersJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - bollywoodhelpline.com

Jan 19, 2026

Jan 15, 2026

Dividend Watch: Is PharmaCyte Biotech Inc in a bullish channelJuly 2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn

Jan 15, 2026

Jan 15, 2026

PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 4.3% – Time to Sell? - Defense World

Jan 15, 2026

Jan 13, 2026

Bull Run: Why PharmaCyte Biotech Inc stock attracts high net worth investorsInsider Selling & Weekly Breakout Watchlists - Bộ Nội Vụ

Jan 13, 2026

Jan 10, 2026

PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN

Jan 10, 2026

Jan 09, 2026

Hedge Fund and Insider Trading News: Paul Singer, Steve Cohen, Israel Englander, Ray Dalio, Rokos Capital Management, Viking Global, PharmaCyte Biotech Inc (PMCB), Cloudflare Inc (NET), and More - Insider Monkey

Jan 09, 2026

Jan 09, 2026

Why PharmaCyte Biotech Inc. stock could see breakout soonJuly 2025 Retail & Daily Growth Stock Tips - Улправда

Jan 09, 2026

Jan 09, 2026

Why PharmaCyte Biotech Inc. stock appeals to analystsJuly 2025 Outlook & Technical Entry and Exit Tips - Улправда

Jan 09, 2026

Jan 08, 2026

Will PharmaCyte Biotech Inc. stock rally after Fed decisionsWeekly Stock Report & Low Drawdown Trading Strategies - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How currency fluctuations impact PharmaCyte Biotech Inc. stockEarnings Summary Report & Long-Term Safe Investment Ideas - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will PharmaCyte Biotech Inc. stock keep outperforming rivals2025 Sector Review & Risk Controlled Stock Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria

Jan 08, 2026

Jan 07, 2026

PMCB Stock Insider Trading Activity - Quiver Quantitative

Jan 07, 2026

Jan 07, 2026

Pharmacyte Biotech CEO Silverman buys $80k in shares By Investing.com - Investing.com Nigeria

Jan 07, 2026

Jan 07, 2026

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 - Investing.com

Jan 07, 2026

Jan 07, 2026

Pharmacyte Biotech CEO Silverman buys $80k in shares - Investing.com

Jan 07, 2026

Jan 06, 2026

How institutional buying supports PharmaCyte Biotech Inc. stockEarnings Per Share Trends & Minimal Investment Trading Tips - ulpravda.ru

Jan 06, 2026

Jan 01, 2026

PharmaCyte Biotech (PMCB) Stock Analysis Report | Financials & Insights - Benzinga

Jan 01, 2026

Dec 31, 2025

Largest borrow rate increases among liquid names - TipRanks

Dec 31, 2025